ACSS2-dependent histone acetylation improves cognition in mouse model of Alzheimer's disease.

Authors:
Lin Y; Lin A; Cai L; Huang W; Yan S and 10 more

Journal:
Mol Neurodegener

Publication Year: 2023

DOI:
10.1186/s13024-023-00625-4

PMCID:
PMC10339567

PMID:
37438762

Journal Information

Full Title: Mol Neurodegener

Abbreviation: Mol Neurodegener

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll animal protocols were approved by the Institutional Animal Care and Use Committee at Fujian Medical University (IACUC FJMU 2021-0272).Human postmortem brain tissues were approved by the Ethics Board at Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College (approval no. 009-2014). Consent for publicationNot applicable. Competing interestsThe authors report no biomedical financial interests or potential conflicts of interest. Competing interests The authors report no biomedical financial interests or potential conflicts of interest."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (No. U21A20362, No. U22A20298, No. 82271468) and National Science and Technology Innovation 2030 Major Projects (No. 2022ZD0211600), granted by the Joint Fund for Science and Technology Innovation of Fujian (No. 2018Y9057, No. 2018Y9095, No. 2019Y9078), and Fujian Provincial Key Scientific and Technological Innovation Projects (No. 2022XH020)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025